Exercise referral to fitness centre or cardiac rehabilitation among breast cancer survivors

Exercise referral to fitness centre or cardiac rehabilitation among breast cancer survivors: Pilot single-arm trial with embedded process evaluation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN11183372

Enrollment

Registered

2016-02-04

Start date

2016-09-01

Completion date

Unknown

Last updated

2018-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer Cancer Breast cancer

Interventions

Participants will be offered a choice of the two interventions: Cardiac Rehabilitation Phase III cardiac rehabilitation is usually a 10 to 12 week exercise programme delivered to patients within a tr

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Are aged 16 years of age or over 2. Diagnosed with breast cancer (any stage) or Ductal Carcinoma In-Situ (DCIS) having surgery, axillary surgery, or undergoing risk-reducing mastectomy 2. Post-surgery and may (or may not) be having adjuvant therapy (chemotherapy and/or radiotherapy) and may have had neoadjuvant therapy before surgery No longer appliable as of 25/07/2016: 3. Live within a 35-mile radius of cardiac rehabilitation/fitness centre

Exclusion criteria

Exclusion criteria: 1. A clinician (e.g. consultant or clinical nurse specialist) decides that they are unsuitable for inclusion 2. A clinician decides that the BCS has a cognitive impairment and thereby cannot give informed consent 3. Scheduled to have further surgery in the next 12 weeks

Design outcomes

Primary

Measure	Time frame
Physical Activity and sedentary behaviour is measured using an accelerometer, the Godin-Shephard Leisure-Time Physical Activity Questionnaire (GSLTPAQ), a physical activity self-efficacy self-report questionnaire and analysing an activity diary at baseline and the end of the intervention.	—

Secondary

Measure	Time frame
1. Quality of life is measured using the EQ-5D questionnaire and the Functional Assessment of Cancer Therapy for Breast cancer (FACT-B) questionnaire at baseline and the end of the intervention 2. Fatigue is measured using an additional questions in the FACT-B questionnaire at baseline and the end of the intervention 3. Functional strength is measured using the five repetition sit to stand test at baseline and the end of the intervention 4. Confounding/mediating factors are determined using patient records at baseline and the end of the intervention	—

Measure

Time frame

1. Quality of life is measured using the EQ-5D questionnaire and the Functional Assessment of Cancer Therapy for Breast cancer (FACT-B) questionnaire at baseline and the end of the intervention 2. Fatigue is measured using an additional questions in the FACT-B questionnaire at baseline and the end of the intervention 3. Functional strength is measured using the five repetition sit to stand test at baseline and the end of the intervention 4. Confounding/mediating factors are determined using patient records at baseline and the end of the intervention

—

Countries

United Kingdom

Contacts

Public ContactGill Hubbard

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 6, 2026